-
1.发明公开
公开(公告)号：EP3215509A4
公开(公告)日：2018-03-14
申请号：EP15856385
申请日：2015-11-06
IPC分类号： C07D487/04 , A61K31/519 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P43/00
CPC分类号： C07D487/04 , C07D519/00
摘要： The invention provides substituted pyrrolo[l,2-a]pyrimi dines and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted pyrrolo[1,2-a]pyrimidines compounds described herein include substituted 2,4-dimethyl-N-phenylpyrrolo[l,2-a]pyrimidine-8-carboxamide compounds and variants thereof.
-
2.发明公开
公开(公告)号：EP3215511A4
公开(公告)日：2018-02-28
申请号：EP15857508
申请日：2015-11-06
IPC分类号： C07D487/04 , A61K31/519 , A61P3/10 , A61P13/12 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P27/06 , A61P43/00
CPC分类号： C07D487/04 , A61K31/519
摘要： The invention provides substituted pyrazolol1,5-alpyrimidine and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted pyrazolo111,5-alpyrimidine compounds described herein include 5,7-dimethyl-N-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide compounds and variants thereof.
-
3.发明公开
公开(公告)号：EP3215510A4
公开(公告)日：2018-04-11
申请号：EP15856978
申请日：2015-11-06
IPC分类号： C07D487/04 , A61K31/519 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P43/00 , C07D519/00
CPC分类号： A61K31/519 , A61K31/13 , A61K31/16 , A61K2300/00 , C07D487/04 , C07D519/00
摘要： The invention provides substituted imidazo┌1,5-a┐pyrimidines and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,5-a]pyrimidine compounds described herein include substituted 2,4-dimethyl-N-phenylimidazo[1,5-a]pyrimidine-8-carbox-amide compounds and variants thereof.
-
-
搜索结果
3 条记录 (耗时 0.007 秒)
